About that Apple HealthKit hospital rollout….

About that Apple HealthKit hospital rollout….

Reuters has an exclusive report this morning about hospitals rolling out pilot programs using Apple’s HealthKit. If you work in this business no doubt link to it have flown through your Twitter feed all morning. If you read the MacRumors version of the article, it’s obviously all-Apple, but there’s a bunch of interesting things that are being overlooked in the Reuters report. We shouldn’t be surprised by this. When Apple rolled out the HealthKit announcement, they indicated they were working with many of the EMR providers to begin integrating data collection….

Everything wrong with health tech reporting in one article

Everything wrong with health tech reporting in one article

Before I delve into this rant, let me start by saying that Business Insider isn’t exactly the Economist of technology reporting. I’d equate it more to a poor man’s HuffPo, but the format of their SEO-optimized clickbait articles (or listicles in this case) means that they permeate the web at a high volume. Good for their ad rates, natch, but bad for informing the public at large in any meaningful way. I write this because these types of articles shape the opinions of a large number of people who don’t…

Pharma Still Sucks At Digital: A Manifesto

Pharma Still Sucks At Digital: A Manifesto

In the movie Jerry Maguire, Tom Cruise’s character has a crisis of conscience. One evening during a league meeting crafts a manifesto of sorts about how sports agents, colleagues, and competitors, could all do a better job serving the best interests of their clients. In the fever pitch of finishing this document, he distributes copies to every single person at the meeting and is greeted with uproarious applauses of approval by his fellow agents. A week later Jerry had lost all but one of his clients, and his career was…

Who Responds To The Responders?

Who Responds To The Responders?

As I thought it might, my last post about social media stirred quite a bit of discussion. As such, I thought it would be useful to perhaps dedicate another post as a means of both clarifying my position, and providing some counter-points to the various responses that have been generated around the web. To recap, my original post wasn’t meant to suggest that pharma should completely abandon social media, but rather that the interest in social engagements is over-calibrated when weighed against the potential business impact for a given brand….